Investment Rating - The report initiates coverage with a "Buy" rating for the company [7] Core Insights - The company, 科捷智能, focuses on intelligent logistics and manufacturing, having successfully delivered over 1,000 projects across more than 20 countries [5][14] - The company has a robust order backlog of 4.291 billion yuan, with a year-on-year increase of 70%, indicating a potential performance turning point [6][26] - The strategic partnership with 星动纪元 aims to advance the logistics robotics sector, enhancing automation and efficiency in logistics operations [5][40] Summary by Sections 1. Focus on Core Business and Robotics Layout - 科捷智能 has expanded into intelligent warehousing and manufacturing since its establishment in 2015, with a diverse industry coverage [14] - The company has repurchased shares and canceled them, boosting shareholder confidence after the second-largest shareholder, 顺丰投资, terminated its share reduction plan early [20][24] 2. Abundant Order Backlog and Expected Performance Turnaround - The company anticipates a revenue of 2.15 to 2.45 billion yuan for 2025, representing a year-on-year increase of 54% to 76%, with a projected net profit of 29.5 to 34 million yuan [6][28] - The overseas order proportion has increased significantly, with nearly half of the current orders coming from international markets, enhancing revenue structure and profitability [6][30] 3. Strategic Cooperation with 星动纪元 - The partnership focuses on the commercialization and large-scale application of humanoid robots in logistics, aiming to redefine the industry landscape [40][41] - The collaboration is expected to lead to innovative solutions that integrate humanoid robotics with intelligent logistics and manufacturing systems [41][42] 4. Profit Forecast and Investment Recommendations - Revenue projections for 2025-2027 are estimated at 2.27 billion, 3.27 billion, and 4.35 billion yuan, with respective year-on-year growth rates of 62.85%, 44.05%, and 33.04% [7][56] - The report highlights a significant improvement in profitability, with net profits expected to rise sharply in the coming years [7][56]

Investment Rating - The report initiates coverage with a "Buy" rating for the company [7] Core Views - The company, 科捷智能, established in 2015, has expanded into intelligent logistics, intelligent manufacturing, and new energy sectors, successfully delivering over 1,000 projects in more than 20 countries [5][14] - The company has a robust order backlog, with orders amounting to 4.291 billion yuan as of Q3 2025, representing a year-on-year increase of 70% [6][26] - The company has terminated a share reduction plan by its second-largest shareholder, 顺丰投资, and has repurchased and canceled shares, boosting market confidence [5][20] Summary by Sections 1. Focus on Core Business and Robotics Layout - The company focuses on intelligent logistics and manufacturing, having successfully delivered projects across various industries including e-commerce and healthcare [14] - A strategic partnership with 星动纪元 was established to develop humanoid robots for logistics applications, marking a significant step in integrating robotics with intelligent logistics [14][40] 2. Strong Order Backlog and Expected Performance Turnaround - The company anticipates a turnaround in performance with projected revenues for 2025 ranging from 2.15 billion to 2.45 billion yuan, reflecting a year-on-year increase of 54% to 76% [6][28] - The company’s overseas orders have significantly increased, with a forecasted 200% rise in foreign revenue for 2025 compared to 2024 [30][37] 3. Strategic Cooperation with 星动纪元 - The partnership aims to commercialize humanoid robots in logistics, enhancing operational efficiency and addressing industry challenges [40][41] - The collaboration is expected to lead to innovative solutions that integrate technology and logistics, driving industry advancements [41][42] 4. Earnings Forecast and Investment Recommendations - Revenue projections for 2025-2027 are estimated at 2.27 billion, 3.27 billion, and 4.35 billion yuan, with respective year-on-year growth rates of 62.85%, 44.05%, and 33.04% [7][56] - The report highlights a significant improvement in profitability, with net profits expected to rise sharply in the coming years [7][56]

证 券 研 究 报 告 科技厂商年报业绩预告陆续披露，AI 驱 动业绩增长 ——先进科技主题 20250202-20260208 [Table增_R持at（ing维] 持） [行Ta业ble_Industry] : 电子 日期: shzqdatemark 2026年02月11日 | E-mail: | yanfeng@shzq.com | | --- | --- | | SAC 编号: | S0870525030001 | | 分析师: | 李心语 | | SAC 编号: | S0870525040001 | 行 业 动 态 [最Ta近bl一e_年Qu行o业teP指ic数] 与沪深 300 比较 [T相ab关le报_R告e：portInfo] 《H200 获准对华出口，AI 终端或受益》 《字节发布豆包 AI 手机，关注端侧机会》 《ASICs 寻求 EMIB 新方案，2026 年晶圆 代工产业有望持续景气》 [Tabl主e_要Su观mm点ary] 【市场回顾】 本周上证指数报收 4065.58 点，周涨跌幅为-1.27%；深证成指报 收 13906.73 点，周涨跌幅为-2.11%；创业板指报收 3236. ...

证 券 研 究 报 告 [Table增_R持at（ing维] 持） | [行Ta业ble_Industry] 汽车 : | | | --- | --- | | 日期: | 2026年02月09日 shzqdatemark | | [T分ab析le师_Author] : | 仇百良 | | E-mail: | qiubailiang@shzq.com | | 编号: SAC | S0870523100003 | | 分析师: | 李煦阳 | | E-mail: | lixuyang@shzq.com | | SAC 编号: | S0870523100001 业 | | [最Ta近bl一e_年Qu行o业teP指ic数] | 与沪深 比较 300 | | 周 | | | 报 | | | 行 | | 周 报 [T相ab关le报_R告e：portInfo] 《特斯拉第三代机器人即将亮相，2025 年 汽车以旧换新初步统计超过 1150 万辆》 《特斯拉计划 27 年面向公众销售 Optimus 机器人，红旗全固态电池首台样车下线》 ——2026 年 01 月 27 日 《中汽协预计 2026 年中国汽车总销量同比 +1 ...

证 券 研 究 报 告 泡泡玛特"星星人"新款热销，关注潮 玩消费与 AI+消费 ——新消费行业周报（20260126-0201） 行业数据： 社会消费品零售总额首破 50 万亿元，规模居全球零售市场前列。结 构持续优化，新的消费热点不断涌现，26 年服务消费与乡村市场有望 是核心引擎。国家统计局公布数据，2025 年社会消费品零售总额 50.12 万亿元，比上年增长 3.7%（比 2024 年加快 0.2 个百分点）。其 中，除汽车以外的消费品零售额 45.14 万亿元，增长 4.4%。全国网上 零售额 15.97 万亿元，比上年增长 8.6%；服务零售额比上年增长 5.5%；最终消费支出对经济增长的贡献率为 52.0%（比上年的贡献率 提高了 5 个百分点）。12 月份，社会消费品零售总额 4.51 万亿元，同 比增长 0.9%。其中，除汽车以外的消费品零售额 3.97 万亿元，增长 1.7%。 ——2026 年 01 月 08 日 服务消费活力释放。从居民消费看，2025 年服务性消费支出占居民人 均消费支出的比重是 46.1%。各地也在持续创新消费场景，优化消费 环境，文化、旅游、娱乐、赛事等细分领域 ...

Investment Rating - The industry investment rating is "Hold" [9] Core Insights - The total retail sales of social consumer goods in 2025 surpassed 50 trillion yuan, with a growth rate of 3.7% compared to the previous year. Online retail sales reached 15.97 trillion yuan, growing by 8.6%, while service retail sales increased by 5.5%. The contribution rate of final consumption expenditure to economic growth was 52.0%, an increase of 5 percentage points from the previous year [3][9] - The 2026 CES showcased a strong embrace of AI technology, focusing on practical applications. Major chip companies like NVIDIA, AMD, and Intel are shifting their attention to physical AI and edge AI, indicating a significant trend in AI hardware development [12][9] - The popularity of collectible toys is rising, with products from Pop Mart, such as the PUCKY series, gaining significant attention and selling out quickly. This trend suggests a potential new focus in the collectible toy market [14][15] Summary by Sections Macro Consumption - In 2025, the retail sales of social consumer goods reached 50.12 trillion yuan, with online retail and service retail sales growing by 8.6% and 5.5%, respectively. The contribution of final consumption to economic growth was 52.0% [3][9] - Service consumption is becoming more vibrant, with a projected 46.1% of per capita consumption expenditure dedicated to service-related spending in 2025. Various sectors like tourism, entertainment, and sports are expected to see double-digit growth [3][11] AI + Consumption - The CES 2026 highlighted the integration of AI in consumer products, with a focus on AI hardware that is becoming more mature and applicable. The emergence of AI glasses and other smart devices indicates a shift towards consumer-grade AI products [12][9] - Companies such as Luxshare Precision, GoerTek, and KANAT Optical are recommended for investment in the AI hardware sector [16] Collectible Toys - Pop Mart's new product lines, including the "Starry Person" series, have quickly sold out, indicating a strong market interest. The resale prices of these products have seen significant increases, suggesting a robust demand in the collectible toy market [15][16]

Investment Rating - The report maintains an "Overweight" rating for the basic chemical industry [10] Core Views - The basic chemical index decreased by 0.86% over the past week, underperforming the CSI 300 index by 0.94 percentage points, ranking 12th among all sectors [3][15] - Key sub-sectors that performed well include compound fertilizers (10.93%), textile chemical products (10.36%), coal chemicals (4.81%), polyurethane (3.75%), and soda ash (2.99%) [3][16] - International crude oil prices continued to rise, with Brent and WTI crude oil futures settling at $70.69 and $65.21 per barrel, respectively, marking increases of 7.30% and 6.78% from the previous week [4] - The price of polyester filament has also increased, with weekly average prices for POY 150D/48F, FDY 150D/96F, and DTY 150D/48F rising by 2.99%, 3.84%, and 2.04%, respectively [5] Summary by Sections Market Trends - The basic chemical index's performance was negative, with a decrease of 0.86% compared to a slight increase of 0.08% in the CSI 300 index [3][15] - The top-performing sub-sectors included compound fertilizers, textile chemical products, and coal chemicals, indicating a mixed performance across the industry [3][16] Chemical Price Trends - The top five products with the highest weekly price increases were international fuel oil (9.66%), adipic acid (9.59%), and octanol (8.84%) [4][24] - Conversely, the products with the largest price declines included NYMEX natural gas (-25.76%) and hydrochloric acid (-15.38%) [4][24] Investment Recommendations - The report suggests focusing on several key sectors: refrigerants, chemical fibers, high-quality companies like Wanhua Chemical, and agricultural chemicals [10][44] - Specific companies to watch include Jinshi Resources, Juhua Co., and Sanmei Co. in the refrigerant sector, and Huafeng Chemical and New Fengming in the chemical fiber sector [10][44]

Investment Rating - The industry investment rating for the pharmaceutical and biotechnology sector is "Hold" [2]. Core Insights - The report highlights significant advancements in the field of metabolic disorders, particularly focusing on the PCSK9 target and small nucleic acid therapies, driven by the increasing prevalence of dyslipidemia in China, which now affects over 400 million people [5][7]. - Novartis' innovative cholesterol-lowering drug, Leqvio (inclisiran), has received approval for a new indication in China, aimed at treating adult patients with primary hypercholesterolemia or mixed dyslipidemia, enhancing treatment adherence and long-term management of LDL-C levels [5][6]. Summary by Sections Industry Overview - The report discusses the acceleration of resource integration and the rapid development of brain-computer interface technologies, indicating a shift towards innovative treatment paradigms in the medical field [4]. Market Dynamics - The number of patients with dyslipidemia in China has significantly increased, with a notable rise in cases of hypercholesterolemia, particularly among younger populations [6]. - The report notes that the global clinical development pipeline for PCSK9-targeted therapies includes 55 projects, with a focus on monoclonal antibodies and emerging small nucleic acid drugs [6]. Investment Recommendations - The report suggests investors pay attention to companies such as Heng Rui Medicine, Innovent Biologics, and East China Pharmaceutical, which are positioned to benefit from advancements in the metabolic disorder treatment landscape [7].

证 券 研 究 报 告 [T日ab期le_Industry] : shzqdatemark 2026年02月04日 | 固 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 定 | | | | | | | | [T分ab析le师_Author] | 张河生 | : | 收 | Tel: | 021-53686158 | 益 | | E-mail: | zhanghesheng@shzq.com | 周 | 编号: | SAC | S0870523100004 | 报 | | [T相ab关le报_R告e：portInfo] | 《国际避险情绪提升与国内投资风险偏好 | | | | | | | 高企》 | ——2026 | 年 | 月 | 日 | 01 | 30 | | 《结构性降息落地与格陵兰岛局势升级》 | ——2026 | 年 | 月 | 日 | 01 | 21 | | 《投资者风险偏好高企》 | ——2026 | 年 | 月 | 日 | 01 | 13 | [T相ab关le报_R告e：portInfo] 《国际避险情绪提升与国内投资风险 ...

- The satellite ETF (159206.SZ) tracks the China Commercial Satellite Communication Industry Index (980018.CNI), and the best convergent stock during the period from October 30, 2025, to January 30, 2026, was identified as Shanghai Hanxun (300762.SZ), selected based on the deviation of component stocks from the satellite communication index and research coverage[3][10] - Shanghai Hanxun's valuation at the end of 2024 was 16x PS (Price-to-Sales ratio). Using linear extrapolation of 2027 and 2026 consensus revenue forecasts, the 2028 expected revenue was calculated and multiplied by 16x PS to estimate the 2028 fundamental value per share at 60.87 RMB. The highest stock price on January 14, 2026, was 60.77 RMB, which closely aligns with the 2028 expected fundamental value, indicating that the recent peak price reflects the growth expectations for the next three years[3][10] - The five major weighted stocks of the satellite ETF as of January 30, 2026, were Aerospace Electronics, China Satellite, Raytron Technology, Sunway Communication, and Zhenlei Technology, with a combined weight of 32.76%. For example, Aerospace Electronics showed a maximum price increase of 457.67% since 2024, while its cumulative net profit growth from 2023 to 2028 was expected to be 132.37%, highlighting a significant gap between market performance and fundamental growth expectations. Similar trends were observed for the other four stocks[4][11]